Fenbufen, a new butanoic acid derivative with anti-inflammatory properties, was evaluated in an open-label study. It was found that fenbufen was an effective anti-inflammatory agent with tolerable and acceptable potential side-effects. Its advantages appeared to be its long clinical half-life and relatively mild toxicity and/or allergic response.
Get full access to this article
View all access options for this article.
References
1.
FranchimontP (1976) Clinical and biochemical assessment of anti-inflammatory substances. Agents and Actions6, 369.
2.
HuskissonE C (1974) Measurement of pain. Lancet2, 1127.
3.
HuskissonE C (1976) New approaches to anti-rheumatic drugs. Agents and Actions6, 342.
4.
LombardinoJ G (1975) Acidic anti-inflammatory agents: Correlations of some physical pharmacological and clinical data. Arzneimittel-Forschung (Drug Research)25, 10, 1629.
5.
RopesM W (1956) Proposed diagnostic criteria for rheumatoid arthritis. Bull. Rheum. 7, 121.
6.
RopesM W (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull. Rheum. 9, 175.
7.
SteelTorrie (1960) Principals of Procedures of Statistics. McGraw-Hill. p 306.
8.
WillkensR FO'BrienW M (1973–1974) New non-steroidal anti-inflammatory drugs (NSAID). Bull. Rheum. 24, 8–9, 770.
9.
WillkensR F (1978) The use of non-steroidal anti-inflammatory agents. Journal of the American Medical Association240, 1632.
